---
title: "SeaStar Medical Holding Corp reports results for the quarter ended December 31 - Earnings Summary"
description: "SeaStar Medical Holding Corp reported a quarterly adjusted loss of 90 cents per share for the quarter ended December 31, exceeding last year's loss of $5.50. Revenue was $67,000, below the expected $1"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/233522716.md"
published_at: "2025-03-27T21:52:58.000Z"
---

# SeaStar Medical Holding Corp reports results for the quarter ended December 31 - Earnings Summary

> SeaStar Medical Holding Corp reported a quarterly adjusted loss of 90 cents per share for the quarter ended December 31, exceeding last year's loss of $5.50. Revenue was $67,000, below the expected $150,000. The company incurred a total loss of $4.42 million. Despite the losses, shares rose by 25.3% this quarter. Analysts maintain a "buy" rating, with a median 12-month price target of $7.00. No earnings estimate revisions occurred in the last 30 days.

-   SeaStar Medical Holding Corp reported a quarterly adjusted loss of 90 cents​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of $-5.50. The lone analyst forecast for the quarter was for a loss of 89 cents per share.
    
-   Revenue was $67.00 thousand​; analysts expected $150.00 thousand.
    
-   SeaStar Medical Holding Corp's reported EPS for the quarter was a loss of 90 cents​.
    
-   The company reported a quarterly loss of $4.42 million.
    
-   SeaStar Medical Holding Corp shares had risen by 25.3% this quarter.
    

FORECAST CHANGES

-   The mean earnings estimate of analysts was unchanged in the last three months.​
    
-   In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
    

RECOMMENDATIONS

-   The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"
    
-   Wall Street's median 12-month price target for SeaStar Medical Holding Corp is $7.00
    

This summary was machine generated from LSEG data March 27 at 09:52 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING

ESTIMATE

ACTUAL

BEAT, MET, MISSED

Dec. 31 2024

\-0.89

\-0.90

Missed

Sep. 30 2024

\-1.13

\-1.10

Beat

Jun. 30 2024

\-1.41

\-1.03

Beat

Mar. 31 2024

\-3.75

\-4.75

Missed

### Related Stocks

- [ICU.US - SeaStar Medical](https://longbridge.com/en/quote/ICU.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Unitil Corp Files For Offering Of Up To $50 Mln Common Stock | Unitil Corp :UNITIL CORP FILES FOR OFFERING OF UP TO $50 MILLION COMMON STOCK - SEC FILING | [Link](https://longbridge.com/en/news/276391384.md) |
| Dynamix Corp IV Files For $175 Mln IPO | Dynamix Corp :BLANK CHECK COMPANY DYNAMIX CORP IV - FILES FOR$175 MILLION IPO - SEC FILINGDYNAMIX CORP - INTENDS TO LIST | [Link](https://longbridge.com/en/news/276180467.md) |
| Plutonian Acquisition Corp II Plans $100 Mln IPO | BLANK CHECK COMPANY PLUTONIAN ACQUISITION CORP II PLANS $100 MILLION IPO - SEC FILINGPLUTONIAN ACQUISITION CORP II: A.G. | [Link](https://longbridge.com/en/news/276180561.md) |
| Mercor.Io Corp Raises About $330.4 Mln In Equity Financing | Mercor.Io Corp:MERCOR.IO CORP SAYS IT HAS RAISED ABOUT $330.4 MILLION IN EQUITY FINANCING - SEC FILING | [Link](https://longbridge.com/en/news/276256778.md) |
| These Analysts Cut Their Forecasts On Waystar After Q4 Results | Waystar Holding Corp (NASDAQ:WAY) reported mixed Q4 results, with earnings of 36 cents per share missing estimates, but  | [Link](https://longbridge.com/en/news/276260564.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.
